A Study of a Urine Test to Detect Colorectal Cancer

Purpose

The purpose of this study is to find out whether a urine test can detect colorectal cancer (CRC) and precancerous polyps in participants living in Ghana, Tanzania, and South Africa.

Conditions

  • Colorectal Cancer
  • Precancerous Polyp
  • Rectal Bleeding
  • CRC

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Criteria

Inclusion Criteria:

- Patient presents with one of the following:

- Patients with symptoms of CRC (such as rectal bleeding for a week) -OR-

- Patients who present for a screening colonoscopy -OR-

- Has received one of the following within 3 weeks of the planned urine
collection

- Patients with a pathologic diagnosis of CRC either by colonoscopy or
resection specimens -OR-

- Patients with colonoscopy demonstrating adenomatous polyps -OR-

- Patients with colonoscopy demonstrating no colon or premalignant or
malignant pathology

- Age ≥ 18

- Willingness to participate in the study

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Participants with Colorectal Cancer/CRC Participants will either have symptoms of colorectal cancer/CRC, presented for a screening colonoscopy, or one of the following: pathologic diagnosis of CRC, colonoscopy demonstrating adenomatous polyps, or colonoscopy demonstrating no colon or premalignant or malignant pathology
  • Diagnostic Test: 3-metabolite biosensor
    3-metabolite biosensor will identify participants with colorectal cancer (CRC) and precancerous polyps

Recruiting Locations

Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York 10065
Contact:
Peter Kingham, MD
212-639-5260

More Details

Status
Recruiting
Sponsor
Memorial Sloan Kettering Cancer Center

Study Contact

Peter Kingham, MD
212-639-5260
kinghamP@mskcc.org